Inhaled nitric oxide and pulmonary vasoreactivity

Citation
M. Aranda et Rg. Pearl, Inhaled nitric oxide and pulmonary vasoreactivity, J CLIN M C, 16(5-6), 2000, pp. 393-401
Citations number
53
Categorie Soggetti
Aneshtesia & Intensive Care
Journal title
JOURNAL OF CLINICAL MONITORING AND COMPUTING
ISSN journal
13871307 → ACNP
Volume
16
Issue
5-6
Year of publication
2000
Pages
393 - 401
Database
ISI
SICI code
1387-1307(2000)16:5-6<393:INOAPV>2.0.ZU;2-Z
Abstract
Inhaled nitric oxide is a ubiquitous molecule which is produced endogenousl y and is also found in air pollution and in cigarette smoke. After describi ng the chemistry of NO, we review its history from the first description in 1980 to the current clinical indications. The biosynthesis of NO, its effe cts on pulmonary vasoreactivity, and the administration of inhaled NO will be described. The indications, uses, and side effects of inhaled NO are dis cussed with an emphasis on withdrawal of NO therapy, specifically the "rebo und" phenomenon. Possible drug interactions are listed. Inhaled nitric oxid e is here to stay, and future studies will provide more information on its therapeutic dose, duration and potential toxicity.